Ampio Pharmaceuticals (NYSE:AMPE) Coverage Initiated at StockNews.com

StockNews.com assumed coverage on shares of Ampio Pharmaceuticals (NYSE:AMPE) in a research note issued on Friday. The firm set a “sell” rating on the stock.

Ampio Pharmaceuticals Stock Performance

AMPE stock opened at $0.00 on Friday. Ampio Pharmaceuticals has a fifty-two week low of $0.00 and a fifty-two week high of $2.47. The company’s 50 day moving average price is $0.02 and its 200 day moving average price is $0.02. The firm has a market capitalization of $2,951.00, a price-to-earnings ratio of 0.00 and a beta of 3.71.

About Ampio Pharmaceuticals

Ampio Pharmaceuticals, Inc, a biopharmaceutical company, develops therapies for the treatment of osteoarthritis of the knee (OAK) in the United States. It develops OA-201, a small molecule formulation for the treatment of OAK pain. The company is headquartered in Englewood, Colorado.